Summary : Marksans Pharma Limited (Reuters: MARK.BO; Bloomberg: MRKS IN; NSE: MARKSANS; BSE: 524404) has received final approval from US Food &…
Pharmanews
-
-
AgrochemicalsIntellectual Property (IP)
Jamaica joins International Design and Trademark Systems
by adminby adminSummary : The international systems for trademark and design protection continues to grow with Jamaica the latest country to file instruments of…
-
AbbVieCompaniesGlobal Market
VUITY™ (pilocarpine HCI Ophthalmic solution) 1.25%, the First and Only FDA-Approved Eye Drop to Treat Age-Related Blurry Near Vision (Presbyopia), is Now Available
by adminby adminHighlights – Presbyopia, or age-related blurry near vision, is a common, progressive condition that reduces the eye’s ability to focus on near…
-
Agro Science & ResearchAgrochemicals
Anupam Rasayan India Sign LOI worth $95 mil. from crop Protection Firm
by adminby adminSummary : Anupam Rasayan India, a custom synthesis & speciality chemical firm, has signed a letter of intent (LoI) worth $95 million…
-
AgrochemicalsGlobal Market
New Johnson & Johnson CEO Duato points out 5 Pipeline Meds that can Generate $5B+
by adminby adminSynopsis: –By 2025, the company aims to generate $60 billion in pharma sales, leaning mostly on existing medicines for growth until then,…
-
Synopsis: The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary…
-
AgrochemicalsGlobal Market
The NICE recommends Rinvoq for Psoriatic Arthritis Patients
by adminby adminSummary : -The National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination (FAD) recommending Rinvoq (upadacitinib) 15mg…
-
AgrochemicalsGlobal MarketIndiaLaunch
Cadila Pharma expands Oncology Portfolio with Launch of Tarzed
by adminby adminSynopsis : TARZED is considered safe and more efficacious compared to conventional treatment medicines for breast cancer. Cadila Pharmaceuticals Limited on Wednesday…
-
AgrochemicalsGlobal Market
Nordic Nanovector Provides update on PARADIGME, its Phase 2b Pivotal Trial with Betalutin® in R/R Follicular Lymphoma
by adminby adminSummary : –Nordic Nanovector ASA (OSE: NANOV) provides an update on the timeline for PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin® (177Lu…
-
AgrochemicalsGlobal Market
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
by adminby adminSummary : Rigel Pharmaceuticals, Inc. Inducement Plan, as amended, with a grant date of January 6, 2022, as an inducement material to…